Minimizing and Managing Toxicities to Maintain Patients on BTK Inhibitor Therapy

Help keep your patients on BTK inhibitor treatment with this online AE management tool supported by an expert commentary and a downloadable resource for clinicians to discuss with patients.

Share

Program Content

Activities

BTK AE Management
How I Manage Adverse Events Associated With BTK Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2019

Expires: March 06, 2020

Activities

BTK Inhibitors: Patient Resource
BTK Inhibitor Therapy: A Guide For Patients and Their Caregivers
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: June 20, 2019

Expires: June 18, 2020

Faculty

cover img faculity

Jeremy S Abramson, MD, MMSc

Director, Center for Lymphoma
Mass General Cancer Center
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Janssen administered by Scientific Affairs

Pharmacyclics an AbbVie Company